Source: Channel NewsAsia

DYNALABS: Lab that tested US execution drug will no longer accept lethal injection samples

Read full article »
DYNALABS's Competitors | DYNALABS's News | DYNALABS's Financials
Stay up-to-date with the latest news on Dynalabs
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Russell Odegard's photo - Co-CEO of Dynalabs

Co-CEO

Russell Odegard

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on Dynalabs